Changes in skin cancer management : a personal perspective.

Even though changes in practice trends for skin cancer therapy are slow, new developments continue, some driven by technology and some driven by socioeconomic factors. Clearly, traditional surgical removal will remain the predominant mode of tumor therapy for the foreseeable future. There will probably be a continued trend of more excision and less ED&C treatment as well as less use of radiation therapy. Medical therapy will likely continue to be used as a surgical alternative, driven by patient demand more than physician choice, but it is doubtful that medical therapy will ever rival surgical technique in terms of numbers in the foreseeable future. Combination therapy with traditional surgery and adjuvant use of medical treatments, such as imiquimod, will likely expand significantly, since it does not threaten any economic considerations and is simply an improvement in outcome over surgery alone. I feel, as dermatologists, we can look forward to being more involved in the treatment of skin cancer than ever before and to newer drugs and methods of treatment as well as combination therapy, which will give us an even greater ability to tailor treatment to individual patients to achieve the desired outcome. All of this will make it difficult for us to be replaced by generalists, which is a good thing, both for us and for our patients.

[1]  D. V. Von Hoff,et al.  Basal cell nevus syndrome: a brave new world. , 2010, Archives of dermatology.

[2]  Howard W. Rogers,et al.  A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. , 2009, Journal of the American Academy of Dermatology.

[3]  S. Konda,et al.  Do postsurgical interventions optimize ultimate scar cosmesis. , 2009, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[4]  D. Rigel,et al.  Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report. , 2008, Journal of drugs in dermatology : JDD.

[5]  B. Berman Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas. , 2008, Journal of drugs in dermatology : JDD.